According to a recent LinkedIn post from Cornerstone Robotics, the company recently exhibited its Sentire® Surgical System at the EAU26 Annual Congress in London, organized by the European Association of Urology. The post notes that this was the company’s first appearance at the event and that more than 100 surgeons attended in-booth demonstrations and provided positive feedback.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post also indicates that this activity aligns with a broader U.K. strategy, referencing a local business centre and an ongoing clinical evaluation program with Portsmouth Hospitals University NHS Trust. For investors, these developments may signal progress in clinical validation, market awareness, and potential future commercialization opportunities in European robotic surgery, particularly within urology.

